Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria
- PMID: 3258230
- DOI: 10.1159/000238542
Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria
Abstract
Amdinocillin was studied alone and in combination with three other beta-lactam antibiotics (aztreonam, cefoperazone, and ceftriaxone) for activity against gram-negative bacilli. These antibiotic combinations failed to show synergy by the checker-board double-dilution test or by killing kinetic studies. However, amdinocillin did show additive killing action when combined with the other beta-lactam antibiotics studied. Amdinocillin failed to induce or inhibit beta-lactamase production in species of Enterobacteriaceae, but with Pseudomonas aeruginosa, beta-lactamase production was induced. It is concluded that the activity of amdinocillin alone or in combination with another beta-lactam antibiotic should not be more effective in the treatment of infections by gram-negative bacilli than just using the beta-lactam antibiotic alone at a higher dose.
Similar articles
-
In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.Diagn Microbiol Infect Dis. 1988 Feb;9(2):87-96. doi: 10.1016/0732-8893(88)90101-0. Diagn Microbiol Infect Dis. 1988. PMID: 3383549
-
Amdinocillin: a novel penicillin. Antibacterial activity, pharmacology and clinical use.Pharmacotherapy. 1985 Jan-Feb;5(1):1-10. doi: 10.1002/j.1875-9114.1985.tb04448.x. Pharmacotherapy. 1985. PMID: 3885172 Review.
-
Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.Am J Med. 1983 Aug 29;75(2A):21-9. doi: 10.1016/0002-9343(83)90090-6. Am J Med. 1983. PMID: 6311002
-
Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.Eur J Clin Microbiol. 1987 Aug;6(4):460-6. doi: 10.1007/BF02013111. Eur J Clin Microbiol. 1987. PMID: 3117535
-
Therapeutic considerations in using combinations of newer beta-lactam antibiotics.Clin Pharm. 1986 Jan;5(1):24-33. Clin Pharm. 1986. PMID: 3512153 Review.
Cited by
-
Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants.Antimicrob Agents Chemother. 2015 Nov 9;60(1):554-60. doi: 10.1128/AAC.02184-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26552987 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical